These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25595305)

  • 41. Effects of K074 and pralidoxime on antioxidant and acetylcholinesterase response in malathion-poisoned mice.
    dos Santos AA; dos Santos DB; Ribeiro RP; Colle D; Peres KC; Hermes J; Barbosa AM; Dafré AL; de Bem AF; Kuca K; Farina M
    Neurotoxicology; 2011 Dec; 32(6):888-95. PubMed ID: 21723318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
    Maxwell DM; Brecht KM; Sweeney RE
    Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro kinetics of nerve agent degradation by fresh frozen plasma (FFP).
    Wille T; Thiermann H; Worek F
    Arch Toxicol; 2014 Feb; 88(2):301-7. PubMed ID: 24057572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
    Aurbek N; Thiermann H; Szinicz L; Worek F
    Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
    Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
    Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximes.
    Worek F; Wille T; Koller M; Thiermann H
    Chem Biol Interact; 2013 Mar; 203(1):125-8. PubMed ID: 22827894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers.
    Pang Z; Hu CM; Fang RH; Luk BT; Gao W; Wang F; Chuluun E; Angsantikul P; Thamphiwatana S; Lu W; Jiang X; Zhang L
    ACS Nano; 2015 Jun; 9(6):6450-8. PubMed ID: 26053868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents.
    Mercey G; Verdelet T; Renou J; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
    Acc Chem Res; 2012 May; 45(5):756-66. PubMed ID: 22360473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Restoration of nerve agent inhibited muscle force production in human intercostal muscle strips with HI 6.
    Seeger T; Niessen KV; Langer P; Gerhardus J; Worek F; Friess H; Bumm R; Mihaljevic AL; Thiermann H
    Toxicol Lett; 2011 Sep; 206(1):72-6. PubMed ID: 21803135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Synthesis of reactivators of phosphorylated acetylcholinesterase of bis-pyridiniumdialdoxime type with a 3-oxapentane connecting chain and their testing in vitro on a model of the enzyme inhibited by chlorpyrifos and methylchlorpyrifos].
    Musílek K; Kuca K; Jun D; Dohnal V; Kim TH; Jung YS; Dolezal M
    Ceska Slov Farm; 2006 May; 55(3):115-9. PubMed ID: 16838488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
    Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
    Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug development for the management of organophosphorus poisoning.
    Elsinghorst PW; Worek F; Thiermann H; Wille T
    Expert Opin Drug Discov; 2013 Dec; 8(12):1467-77. PubMed ID: 24125474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Organophosphates and their impact on the global environment.
    Satoh T; Hosokawa M
    Neurotoxicology; 2000; 21(1-2):223-7. PubMed ID: 10794404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonquaternary reactivators for organophosphate-inhibited cholinesterases.
    Kalisiak J; Ralph EC; Cashman JR
    J Med Chem; 2012 Jan; 55(1):465-74. PubMed ID: 22206546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Organophosphate pesticides: biochemistry and clinical toxicology.
    Kwong TC
    Ther Drug Monit; 2002 Feb; 24(1):144-9. PubMed ID: 11805735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment.
    Bajgar J
    Adv Clin Chem; 2004; 38():151-216. PubMed ID: 15521192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Body mass index as a prognostic factor in organophosphate-poisoned patients.
    Lee DH; Jung KY; Choi YH; Cheon YJ
    Am J Emerg Med; 2014 Jul; 32(7):693-6. PubMed ID: 24856742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cholinergic and non-cholinergic effects of organophosphates and oximes in cultured human myoblasts.
    Katalinić M; Miš K; Pirkmajer S; Grubič Z; Kovarik Z; Marš T
    Chem Biol Interact; 2013 Mar; 203(1):144-8. PubMed ID: 23047024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms and treatment strategies of organophosphate pesticide induced neurotoxicity in humans: A critical appraisal.
    Ganie SY; Javaid D; Hajam YA; Reshi MS
    Toxicology; 2022 Apr; 472():153181. PubMed ID: 35439576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.